Share Price and Basic Stock Data
Last Updated: November 3, 2025, 11:28 pm
| PEG Ratio | 0.66 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Continental Chemicals Ltd operates in the IT Consulting & Software sector, with a current market capitalization of ₹16.7 Cr and a share price of ₹74.1. The company has faced fluctuating revenue trends over the last few quarters. Sales stood at ₹0.14 Cr in June 2022 and saw a marginal increase to ₹0.21 Cr by June 2023, before dipping again to ₹0.05 Cr in September 2023. The company’s performance has been inconsistent, with total sales for the trailing twelve months (TTM) reported at ₹0.24 Cr. This decline in revenue can be attributed to increased competition and operational challenges within the sector. The operating profit margin has been notably negative, recorded at -250% in the latest quarter, indicating significant cost pressures that have severely impacted profitability. Historical sales figures reveal a gradual decline from ₹0.58 Cr in March 2014 to ₹0.44 Cr in March 2023, further highlighting the challenges faced by the company in maintaining consistent revenue growth.
Profitability and Efficiency Metrics
Continental Chemicals Ltd has reported a net profit of ₹0.47 Cr, translating to a P/E ratio of 35.5, which is relatively high compared to typical industry benchmarks. However, the company has consistently struggled with profitability, as evidenced by its operating profit margin (OPM) of -250%. The negative margins indicate a serious imbalance between revenues and expenses, which stood at ₹0.88 Cr for FY 2023. The return on equity (ROE) is recorded at 9.15%, while return on capital employed (ROCE) is at 10.7%, suggesting that the company is generating a modest return on its equity and capital. In terms of operational efficiency, the interest coverage ratio (ICR) is a strong 15.52x, indicating that the company can comfortably meet its interest obligations. However, the negative OPM and declining sales raise concerns about the sustainability of profitability moving forward, necessitating strategic improvements to enhance operational effectiveness.
Balance Sheet Strength and Financial Ratios
The balance sheet of Continental Chemicals Ltd reflects a conservative leverage profile, with borrowings reported at just ₹0.03 Cr against total assets of ₹6.04 Cr. This results in a long-term debt-to-equity ratio of 0.01, indicating minimal reliance on debt financing, which is a positive aspect for risk-averse investors. The company’s reserves increased from ₹1.56 Cr in March 2022 to ₹2.78 Cr in March 2025, demonstrating a gradual strengthening of its equity base. The price-to-book value (P/BV) ratio stands at 3.35x, which is relatively high, suggesting that the stock may be overvalued compared to its book value. The current and quick ratios are both reported at 3.47, indicating a strong liquidity position, which allows the company to cover its short-term obligations comfortably. However, the negative operating profit and declining sales trends pose risks to maintaining this balance sheet strength in the long run.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Continental Chemicals Ltd reveals that promoters hold a significant 61.57% stake, which suggests a strong alignment of interests between management and shareholders. The public holds 38.42% of the shares, with a total of 7,160 shareholders as of the latest reporting period. This concentrated ownership by promoters may instill confidence among investors, as it indicates a commitment to the company’s strategic direction. However, the lack of participation from foreign institutional investors (FIIs) and domestic institutional investors (DIIs) raises concerns about broader market confidence in the company. The stable promoter holding over the past quarters suggests that there has not been significant insider selling, which could be perceived as a positive signal. Nevertheless, the overall lack of institutional interest may reflect skepticism regarding the company’s growth prospects, particularly given its recent performance challenges.
Outlook, Risks, and Final Insight
Looking ahead, Continental Chemicals Ltd faces both opportunities and challenges. The company must address its operational inefficiencies to improve profitability and sales growth. Key risks include the persistent negative operating profit margins, which could hinder its ability to attract further investment or strategic partnerships. Additionally, the lack of institutional interest may restrict the company’s ability to raise capital for expansion or innovation. Conversely, the strong liquidity position and low debt levels provide a buffer against financial distress. If the company can stabilize its revenue and enhance profitability through cost management and operational efficiency, it may regain investor confidence. However, without significant strategic changes or improvements in market conditions, the company may continue to struggle in the competitive IT consulting landscape, necessitating critical evaluations of its operational strategies and market positioning.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Continental Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | 0.38/0.33 | 1.12 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 33.6 Cr. | 10.6 | 10.6/4.43 | 0.25 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 157 Cr. | 146 | 194/99.8 | 35.1 | 33.2 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 32.9 Cr. | 257 | 310/140 | 23.5 | 26.7 | 0.39 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 6.55 Cr. | 1.34 | 1.73/0.91 | 59.6 | 2.52 | 0.00 % | 2.14 % | 2.15 % | 2.00 |
| Industry Average | 19,272.22 Cr | 570.43 | 144.55 | 119.27 | 0.53% | 14.92% | 20.95% | 6.84 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.14 | 0.12 | 0.18 | -0.00 | 0.21 | 0.05 | 0.11 | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 |
| Expenses | 0.23 | 0.21 | 0.20 | 0.24 | 0.22 | 0.20 | 0.24 | 0.19 | 0.23 | 0.31 | 0.27 | 0.18 | 0.21 |
| Operating Profit | -0.09 | -0.09 | -0.02 | -0.24 | -0.01 | -0.15 | -0.13 | -0.14 | -0.18 | -0.25 | -0.21 | -0.12 | -0.15 |
| OPM % | -64.29% | -75.00% | -11.11% | -4.76% | -300.00% | -118.18% | -280.00% | -360.00% | -416.67% | -350.00% | -200.00% | -250.00% | |
| Other Income | 0.18 | 0.20 | 0.21 | 0.24 | 0.19 | 0.29 | 0.34 | 0.32 | 0.33 | 0.30 | 0.38 | 0.34 | 0.35 |
| Interest | -0.00 | -0.00 | -0.00 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.05 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| Profit before tax | 0.08 | 0.10 | 0.18 | -0.08 | 0.15 | 0.12 | 0.18 | 0.15 | 0.12 | 0.02 | 0.14 | 0.19 | 0.16 |
| Tax % | -12.50% | 30.00% | 16.67% | -37.50% | 26.67% | 8.33% | 5.56% | 20.00% | 8.33% | -0.00% | 35.71% | -0.00% | 12.50% |
| Net Profit | 0.08 | 0.07 | 0.15 | -0.05 | 0.11 | 0.12 | 0.18 | 0.12 | 0.11 | 0.03 | 0.10 | 0.20 | 0.14 |
| EPS in Rs | 0.36 | 0.31 | 0.67 | -0.22 | 0.49 | 0.53 | 0.80 | 0.53 | 0.49 | 0.13 | 0.44 | 0.89 | 0.62 |
Last Updated: August 19, 2025, 8:45 pm
Below is a detailed analysis of the quarterly data for Continental Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.06 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.06 Cr..
- For Expenses, as of Jun 2025, the value is 0.21 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.18 Cr. (Mar 2025) to 0.21 Cr., marking an increase of 0.03 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.15 Cr.. The value appears to be declining and may need further review. It has decreased from -0.12 Cr. (Mar 2025) to -0.15 Cr., marking a decrease of 0.03 Cr..
- For OPM %, as of Jun 2025, the value is -250.00%. The value appears to be declining and may need further review. It has decreased from -200.00% (Mar 2025) to -250.00%, marking a decrease of 50.00%.
- For Other Income, as of Jun 2025, the value is 0.35 Cr.. The value appears strong and on an upward trend. It has increased from 0.34 Cr. (Mar 2025) to 0.35 Cr., marking an increase of 0.01 Cr..
- For Interest, as of Jun 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
- For Depreciation, as of Jun 2025, the value is 0.03 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.02 Cr. (Mar 2025) to 0.03 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.16 Cr.. The value appears to be declining and may need further review. It has decreased from 0.19 Cr. (Mar 2025) to 0.16 Cr., marking a decrease of 0.03 Cr..
- For Tax %, as of Jun 2025, the value is 12.50%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Mar 2025) to 12.50%, marking an increase of 12.50%.
- For Net Profit, as of Jun 2025, the value is 0.14 Cr.. The value appears to be declining and may need further review. It has decreased from 0.20 Cr. (Mar 2025) to 0.14 Cr., marking a decrease of 0.06 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.62. The value appears to be declining and may need further review. It has decreased from 0.89 (Mar 2025) to 0.62, marking a decrease of 0.27.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:35 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.58 | 0.43 | 0.49 | 0.60 | 0.61 | 0.19 | 0.31 | 0.19 | 0.48 | 0.44 | 0.42 | 0.22 | 0.24 |
| Expenses | 1.07 | 0.61 | 0.72 | 0.86 | 0.86 | 0.93 | 0.89 | 0.67 | 0.84 | 0.88 | 0.85 | 0.98 | 0.97 |
| Operating Profit | -0.49 | -0.18 | -0.23 | -0.26 | -0.25 | -0.74 | -0.58 | -0.48 | -0.36 | -0.44 | -0.43 | -0.76 | -0.73 |
| OPM % | -84.48% | -41.86% | -46.94% | -43.33% | -40.98% | -389.47% | -187.10% | -252.63% | -75.00% | -100.00% | -102.38% | -345.45% | -304.17% |
| Other Income | 0.62 | 0.46 | 0.46 | 0.39 | 0.38 | 1.12 | 0.88 | 0.77 | 0.56 | 0.83 | 1.15 | 1.35 | 1.37 |
| Interest | 0.00 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.05 | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 |
| Depreciation | 0.10 | 0.11 | 0.07 | 0.07 | 0.07 | 0.07 | 0.09 | 0.09 | 0.09 | 0.09 | 0.07 | 0.07 | 0.09 |
| Profit before tax | 0.03 | 0.15 | 0.15 | 0.05 | 0.05 | 0.29 | 0.16 | 0.16 | 0.07 | 0.27 | 0.61 | 0.48 | 0.51 |
| Tax % | 200.00% | -26.67% | 13.33% | 40.00% | 40.00% | -13.79% | 50.00% | 12.50% | 14.29% | 11.11% | 13.11% | 8.33% | |
| Net Profit | -0.04 | 0.19 | 0.13 | 0.04 | 0.03 | 0.34 | 0.08 | 0.14 | 0.06 | 0.25 | 0.52 | 0.44 | 0.47 |
| EPS in Rs | 0.36 | 0.62 | 0.27 | 1.11 | 2.31 | 1.96 | 2.08 | ||||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 575.00% | -31.58% | -69.23% | -25.00% | 1033.33% | -76.47% | 75.00% | -57.14% | 316.67% | 108.00% | -15.38% |
| Change in YoY Net Profit Growth (%) | 0.00% | -606.58% | -37.65% | 44.23% | 1058.33% | -1109.80% | 151.47% | -132.14% | 373.81% | -208.67% | -123.38% |
Continental Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -7% |
| 3 Years: | -23% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 41% |
| 3 Years: | 94% |
| TTM: | -11% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 32% |
| 3 Years: | -9% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 7% |
| 3 Years: | 9% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 3:01 pm
Balance Sheet
Last Updated: July 25, 2025, 1:31 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.99 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 |
| Reserves | 0.12 | 0.31 | 0.45 | 0.50 | 0.54 | 0.88 | 1.33 | 1.49 | 1.56 | 1.82 | 2.34 | 2.78 |
| Borrowings | 0.03 | 0.20 | 0.17 | 0.14 | 0.14 | 0.14 | 0.27 | 0.21 | 0.15 | 0.15 | 0.03 | 0.03 |
| Other Liabilities | 1.15 | 1.12 | 0.98 | 1.02 | 1.10 | 0.87 | 0.84 | 0.91 | 0.96 | 0.86 | 0.95 | 0.98 |
| Total Liabilities | 2.29 | 2.63 | 2.60 | 2.66 | 2.78 | 2.89 | 4.69 | 4.86 | 4.92 | 5.08 | 5.57 | 6.04 |
| Fixed Assets | 1.90 | 2.05 | 1.98 | 1.91 | 1.86 | 1.80 | 1.95 | 1.86 | 1.78 | 1.70 | 2.49 | 2.59 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.39 | 0.58 | 0.62 | 0.75 | 0.92 | 1.09 | 2.74 | 3.00 | 3.14 | 3.38 | 3.08 | 3.45 |
| Total Assets | 2.29 | 2.63 | 2.60 | 2.66 | 2.78 | 2.89 | 4.69 | 4.86 | 4.92 | 5.08 | 5.57 | 6.04 |
Below is a detailed analysis of the balance sheet data for Continental Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 2.25 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.25 Cr..
- For Reserves, as of Mar 2025, the value is 2.78 Cr.. The value appears strong and on an upward trend. It has increased from 2.34 Cr. (Mar 2024) to 2.78 Cr., marking an increase of 0.44 Cr..
- For Borrowings, as of Mar 2025, the value is 0.03 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.03 Cr..
- For Other Liabilities, as of Mar 2025, the value is 0.98 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.95 Cr. (Mar 2024) to 0.98 Cr., marking an increase of 0.03 Cr..
- For Total Liabilities, as of Mar 2025, the value is 6.04 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.57 Cr. (Mar 2024) to 6.04 Cr., marking an increase of 0.47 Cr..
- For Fixed Assets, as of Mar 2025, the value is 2.59 Cr.. The value appears strong and on an upward trend. It has increased from 2.49 Cr. (Mar 2024) to 2.59 Cr., marking an increase of 0.10 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 3.45 Cr.. The value appears strong and on an upward trend. It has increased from 3.08 Cr. (Mar 2024) to 3.45 Cr., marking an increase of 0.37 Cr..
- For Total Assets, as of Mar 2025, the value is 6.04 Cr.. The value appears strong and on an upward trend. It has increased from 5.57 Cr. (Mar 2024) to 6.04 Cr., marking an increase of 0.47 Cr..
Notably, the Reserves (2.78 Cr.) exceed the Borrowings (0.03 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.52 | -0.38 | -0.40 | -0.40 | -0.39 | -0.88 | -0.85 | -0.69 | -0.51 | -0.59 | -0.46 | -0.79 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 35.90 | 0.00 | 58.87 | 76.84 | 15.21 | 0.00 | 0.00 | 0.00 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 35.90 | 0.00 | 58.87 | 76.84 | 15.21 | 0.00 | 0.00 | 0.00 |
| Working Capital Days | -591.55 | -891.28 | -707.65 | -517.08 | -586.39 | -1,248.68 | -741.77 | -1,440.79 | -539.90 | -555.80 | -677.86 | -1,260.91 |
| ROCE % | 2.62% | 15.85% | 10.22% | 3.68% | 3.61% | 16.76% | 7.16% | 5.13% | 2.78% | 7.33% | 14.71% | 10.74% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.94 | 2.30 | 1.11 | 0.27 | 0.64 |
| Diluted EPS (Rs.) | 1.94 | 2.30 | 1.11 | 0.27 | 0.64 |
| Cash EPS (Rs.) | 2.26 | 2.62 | 1.50 | 0.66 | 1.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 22.37 | 20.42 | 18.11 | 16.93 | 16.64 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 22.37 | 20.42 | 18.11 | 16.93 | 16.64 |
| Revenue From Operations / Share (Rs.) | 0.98 | 1.88 | 1.95 | 2.13 | 0.86 |
| PBDIT / Share (Rs.) | 2.63 | 3.17 | 1.76 | 0.87 | 1.30 |
| PBIT / Share (Rs.) | 2.31 | 2.85 | 1.37 | 0.47 | 0.91 |
| PBT / Share (Rs.) | 2.14 | 2.69 | 1.22 | 0.31 | 0.73 |
| Net Profit / Share (Rs.) | 1.94 | 2.30 | 1.11 | 0.26 | 0.63 |
| PBDIT Margin (%) | 266.38 | 168.23 | 90.44 | 41.04 | 150.95 |
| PBIT Margin (%) | 233.75 | 151.43 | 70.23 | 22.34 | 106.24 |
| PBT Margin (%) | 216.58 | 142.87 | 62.66 | 14.72 | 85.45 |
| Net Profit Margin (%) | 195.95 | 122.27 | 56.84 | 12.51 | 73.82 |
| Return on Networth / Equity (%) | 8.66 | 11.28 | 6.12 | 1.57 | 3.83 |
| Return on Capital Employeed (%) | 10.11 | 13.65 | 7.17 | 2.65 | 5.19 |
| Return On Assets (%) | 7.21 | 9.30 | 4.91 | 1.21 | 2.95 |
| Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.03 | 0.03 | 0.04 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.03 | 0.03 | 0.04 |
| Asset Turnover Ratio (%) | 0.03 | 0.07 | 0.08 | 0.09 | 0.04 |
| Current Ratio (X) | 3.47 | 3.14 | 3.26 | 2.62 | 2.47 |
| Quick Ratio (X) | 3.47 | 3.14 | 3.26 | 2.62 | 2.47 |
| Interest Coverage Ratio (X) | 15.52 | 19.64 | 11.95 | 5.38 | 7.26 |
| Interest Coverage Ratio (Post Tax) (X) | 12.41 | 15.28 | 8.51 | 2.64 | 4.55 |
| Enterprise Value (Cr.) | 13.92 | 14.23 | 14.99 | 26.92 | 1.07 |
| EV / Net Operating Revenue (X) | 62.57 | 33.58 | 34.17 | 56.21 | 5.50 |
| EV / EBITDA (X) | 23.49 | 19.96 | 37.78 | 136.97 | 3.65 |
| MarketCap / Net Operating Revenue (X) | 75.81 | 39.80 | 39.39 | 60.41 | 15.40 |
| Price / BV (X) | 3.35 | 3.67 | 4.24 | 7.60 | 0.79 |
| Price / Net Operating Revenue (X) | 75.83 | 39.80 | 39.41 | 60.43 | 15.41 |
| EarningsYield | 0.02 | 0.03 | 0.01 | 0.00 | 0.04 |
After reviewing the key financial ratios for Continental Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.94. This value is below the healthy minimum of 5. It has decreased from 2.30 (Mar 24) to 1.94, marking a decrease of 0.36.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.94. This value is below the healthy minimum of 5. It has decreased from 2.30 (Mar 24) to 1.94, marking a decrease of 0.36.
- For Cash EPS (Rs.), as of Mar 25, the value is 2.26. This value is below the healthy minimum of 3. It has decreased from 2.62 (Mar 24) to 2.26, marking a decrease of 0.36.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.37. It has increased from 20.42 (Mar 24) to 22.37, marking an increase of 1.95.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.37. It has increased from 20.42 (Mar 24) to 22.37, marking an increase of 1.95.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.98. It has decreased from 1.88 (Mar 24) to 0.98, marking a decrease of 0.90.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.63. This value is within the healthy range. It has decreased from 3.17 (Mar 24) to 2.63, marking a decrease of 0.54.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.31. This value is within the healthy range. It has decreased from 2.85 (Mar 24) to 2.31, marking a decrease of 0.54.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.14. This value is within the healthy range. It has decreased from 2.69 (Mar 24) to 2.14, marking a decrease of 0.55.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.94. This value is below the healthy minimum of 2. It has decreased from 2.30 (Mar 24) to 1.94, marking a decrease of 0.36.
- For PBDIT Margin (%), as of Mar 25, the value is 266.38. This value is within the healthy range. It has increased from 168.23 (Mar 24) to 266.38, marking an increase of 98.15.
- For PBIT Margin (%), as of Mar 25, the value is 233.75. This value exceeds the healthy maximum of 20. It has increased from 151.43 (Mar 24) to 233.75, marking an increase of 82.32.
- For PBT Margin (%), as of Mar 25, the value is 216.58. This value is within the healthy range. It has increased from 142.87 (Mar 24) to 216.58, marking an increase of 73.71.
- For Net Profit Margin (%), as of Mar 25, the value is 195.95. This value exceeds the healthy maximum of 10. It has increased from 122.27 (Mar 24) to 195.95, marking an increase of 73.68.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.66. This value is below the healthy minimum of 15. It has decreased from 11.28 (Mar 24) to 8.66, marking a decrease of 2.62.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.11. This value is within the healthy range. It has decreased from 13.65 (Mar 24) to 10.11, marking a decrease of 3.54.
- For Return On Assets (%), as of Mar 25, the value is 7.21. This value is within the healthy range. It has decreased from 9.30 (Mar 24) to 7.21, marking a decrease of 2.09.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.03. It has decreased from 0.07 (Mar 24) to 0.03, marking a decrease of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 3.47. This value exceeds the healthy maximum of 3. It has increased from 3.14 (Mar 24) to 3.47, marking an increase of 0.33.
- For Quick Ratio (X), as of Mar 25, the value is 3.47. This value exceeds the healthy maximum of 2. It has increased from 3.14 (Mar 24) to 3.47, marking an increase of 0.33.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 15.52. This value is within the healthy range. It has decreased from 19.64 (Mar 24) to 15.52, marking a decrease of 4.12.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 12.41. This value is within the healthy range. It has decreased from 15.28 (Mar 24) to 12.41, marking a decrease of 2.87.
- For Enterprise Value (Cr.), as of Mar 25, the value is 13.92. It has decreased from 14.23 (Mar 24) to 13.92, marking a decrease of 0.31.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 62.57. This value exceeds the healthy maximum of 3. It has increased from 33.58 (Mar 24) to 62.57, marking an increase of 28.99.
- For EV / EBITDA (X), as of Mar 25, the value is 23.49. This value exceeds the healthy maximum of 15. It has increased from 19.96 (Mar 24) to 23.49, marking an increase of 3.53.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 75.81. This value exceeds the healthy maximum of 3. It has increased from 39.80 (Mar 24) to 75.81, marking an increase of 36.01.
- For Price / BV (X), as of Mar 25, the value is 3.35. This value exceeds the healthy maximum of 3. It has decreased from 3.67 (Mar 24) to 3.35, marking a decrease of 0.32.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 75.83. This value exceeds the healthy maximum of 3. It has increased from 39.80 (Mar 24) to 75.83, marking an increase of 36.03.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Continental Chemicals Ltd:
- Net Profit Margin: 195.95%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.11% (Industry Average ROCE: 14.92%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.66% (Industry Average ROE: 20.95%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 12.41
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.47
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 33.5 (Industry average Stock P/E: 144.55)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 195.95%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | A-7, Sector-7, Noida, Gautam Budh Nagar Dist. Uttar Pradesh 201301 | info@continentalsoft.com www.continentalchemicalsltd.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Naresh Kumar Chibba | Managing Director |
| Ms. Sunaina Chibba | Director |
| Mr. Aditya Vikram Chibba | Director |
| Mr. Raghav Nathani | Independent Director |
| Mr. Gaurav Sachdeva | Independent Director |
FAQ
What is the intrinsic value of Continental Chemicals Ltd?
Continental Chemicals Ltd's intrinsic value (as of 03 November 2025) is 56.03 which is 19.96% lower the current market price of 70.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 15.7 Cr. market cap, FY2025-2026 high/low of 104/63.0, reserves of ₹2.78 Cr, and liabilities of 6.04 Cr.
What is the Market Cap of Continental Chemicals Ltd?
The Market Cap of Continental Chemicals Ltd is 15.7 Cr..
What is the current Stock Price of Continental Chemicals Ltd as on 03 November 2025?
The current stock price of Continental Chemicals Ltd as on 03 November 2025 is 70.0.
What is the High / Low of Continental Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Continental Chemicals Ltd stocks is 104/63.0.
What is the Stock P/E of Continental Chemicals Ltd?
The Stock P/E of Continental Chemicals Ltd is 33.5.
What is the Book Value of Continental Chemicals Ltd?
The Book Value of Continental Chemicals Ltd is 22.4.
What is the Dividend Yield of Continental Chemicals Ltd?
The Dividend Yield of Continental Chemicals Ltd is 0.00 %.
What is the ROCE of Continental Chemicals Ltd?
The ROCE of Continental Chemicals Ltd is 10.7 %.
What is the ROE of Continental Chemicals Ltd?
The ROE of Continental Chemicals Ltd is 9.15 %.
What is the Face Value of Continental Chemicals Ltd?
The Face Value of Continental Chemicals Ltd is 10.0.